The Globalย Laboratory Automation Marketย size was valued at $4,884 million in 2018, and is projected to reach $8,424 million by 2026, registering a CAGR of 6.9%.
The Laboratory Automation Market refers to the use of technology and equipment to automate laboratory processes, such as sample preparation, data collection and analysis, and other tasks that were previously done manually. This market includes various types of automation technologies, such as robotics, software, and other automated laboratory equipment.
๐ ๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐๐๐ซ๐:ย https://www.alliedmarketresearch.com/request-sample/2708
The lab automation market has been growing steadily over the past few years and is expected to continue growing in the future. The market growth is driven by various factors, including the increasing demand for high-throughput screening, the need for accuracy and reproducibility in laboratory experiments, and the growing demand for personalized medicine.
The lab automation market is segmented into different categories based on various factors such as type, application, end-users, and geography. Some of the key players in the lab automation market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, and PerkinElmer, Inc.
Overall, the lab automation market is expected to continue growing in the future as more laboratories adopt automation technology to improve their efficiency and accuracy. The market is also expected to benefit from advances in technologies such as artificial intelligence and machine learning, which can further enhance the capabilities of lab automation systems.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ):ย https://www.alliedmarketresearch.com/checkout-final/5993e304d7198b86926241c84dcb106
Increase in research & development activities around the globe and increase in implementation in various applications propel the growth of the global laboratory automation market. However, high initial costs related to investment for building automated products restrain the market growth. Contrarily, increase in miniaturized process equipment demand and technological advancements offer numerous opportunities in coming years.
On the basis of product, the equipment segment accounted for more than five-sixths of the total market share in terms of revenue in 2018, and is projected to maintain its lionโs share during the forecast period. Moreover, this segment would grow at the largest CAGR of 7.2% from 2019 to 2026. This is attributed to increase lab automation equipment adoption for drug discovery & diagnostic purposes, less production fluctuations, and increase in demand for miniaturized process equipment. The report also discusses the software and informatics segment.
The clinical diagnostics segment accounted for the highest share in the global laboratory automation market, accounting for nearly two-fifths of the total market share in 2018, and is expected to continue its lead position throughout the forecast period. This is due to accessibility to highly-specialized laboratories that offer advanced automation technology for carrying out analysis with improved efficiency, lower cost, high quality, and low power consumption. However, the genomics solutions segment is estimated to witness the highest CAGR of 10.0% from 2019 to 2026.
North America held the largest market share, accounting for more than two-fifths of the total market share in 2018, and is estimated to grow at the lion’s share throughout the forecast period. This is owing to presence of enhanced healthcare infrastructure and availability of well-trained medical professionals. However, Asia-Pacific would maintain the largest CAGR of 8.3% during the study period.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ-ย https://www.alliedmarketresearch.com/purchase-enquiry/2708
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Cell and gene supply chain services market Share:ย https://www.alliedmarketresearch.com/cell-and-gene-supply-chain-services-market-A08188
Rare Disease Genetic Testing Market Size:ย https://www.alliedmarketresearch.com/rare-disease-genetic-testing-market-A10305
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975